Cochrane Abstracts
Advance misoprostol distribution to pregnant women for preventing and treating postpartum haemorrhage
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Advance Misoprostol Distribution to Pregnant Women for Preventing and Treating Postpartum Haemorrhage." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432676/all/Transmyocardial_laser_revascularization_versus_medical_therapy_for_refractory_angina:_Cochrane_systematic_review. Accessed 18 April 2024.
Advance misoprostol distribution to pregnant women for preventing and treating postpartum haemorrhage. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432676/all/Transmyocardial_laser_revascularization_versus_medical_therapy_for_refractory_angina:_Cochrane_systematic_review. Accessed April 18, 2024.
Advance misoprostol distribution to pregnant women for preventing and treating postpartum haemorrhage. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432676/all/Transmyocardial_laser_revascularization_versus_medical_therapy_for_refractory_angina:_Cochrane_systematic_review
Advance Misoprostol Distribution to Pregnant Women for Preventing and Treating Postpartum Haemorrhage [Internet]. In: Cochrane Abstracts. [cited 2024 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432676/all/Transmyocardial_laser_revascularization_versus_medical_therapy_for_refractory_angina:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Advance misoprostol distribution to pregnant women for preventing and treating postpartum haemorrhage
ID - 432676
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432676/all/Transmyocardial_laser_revascularization_versus_medical_therapy_for_refractory_angina:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
